You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR QUAZEPAM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for QUAZEPAM

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03708341 ↗	Exogenous Melatonin in Intensive Care Unit Chronodisruption	Unknown status	Saint-Joseph University	Phase 3	2018-11-15	To this day, a small number of studies have evaluated the effect of melatonin on the modifications of the characteristics of sleep in critical care units, with mostly a small studied population. However, no study has been realized on a large population, nor has it evaluated the association between genetic factors and response to treatment (melatonin), hence the originality of our study. In our study we hypothesized that systematic melatonin usage in ICU can ameliorate the total sleep time and the fragmentation index and can decrease the confusion related to sleep deprivation.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for QUAZEPAM

Condition Name

Chart
Table

Condition Name for QUAZEPAM
Intervention	Trials
Intensive Care Psychosis	1
Sleep Deprivation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for QUAZEPAM
Intervention	Trials
Sleep Deprivation	1
Psychotic Disorders	1
Mental Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for QUAZEPAM

Trials by Country

Map
Table

Trials by Country for QUAZEPAM
Location	Trials
Lebanon	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for QUAZEPAM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for QUAZEPAM
Clinical Trial Phase	Trials
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for QUAZEPAM
Clinical Trial Phase	Trials
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for QUAZEPAM

Sponsor Name

Chart
Table

Sponsor Name for QUAZEPAM
Sponsor	Trials
Saint-Joseph University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for QUAZEPAM
Sponsor	Trials
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.